CCR2 and myocardial infarction: We found nominally significant associations of the predicted damaging CCR2 variants with myocardial infarction (OR: 0.60, 95%CI: 0.40–0.90, p=0.008) and coronary artery disease (OR: 0.76, 95%CI: 0.59–0.99, p=0.03), as well as directionally consistent associations with the odds of all other examined outcomes (ischemic stroke, peripheral artery disease, abdominal aortic aneurysm, Figure 2A).